Enhancing the QUAlity and Transparency Of health Research

Search for reporting guidelines

Use your browser's Back button to return to your search results

Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO) : Platelet -Rich Plasma and Mesenchymal Stem Cells

Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
Reporting of clinical studies evaluating platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs).


MIBO PRP checklist (PDF)

MIBO stem cells checklist (PDF)

Full bibliographic reference Murray IR, Geeslin AG, Goudie EB, Petrigliano FA, LaPrade RF. Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): Platelet-Rich Plasma and Mesenchymal Stem Cells. J Bone Joint Surg Am. 2017;99(10):809-819.
Language English
PubMed ID 28509821
Reporting guideline website URL https://www.mibo-statement.org/
Reporting guideline acronym MIBO
Study design Clinical trials, Experimental studies, Observational studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews
Clinical area Rheumatology, Sport and exercise medicine, Surgery
Applies to the whole report or to individual sections of the report? Ethical issues (consent etc.), Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.)
Additional information Murray IR, Murray AD, Geeslin AG, Goudie EB, White TO, Petrigliano FA, LaPrade RF. Infographic: we need minimum reporting standards for biologics. Br J Sports Med. 2017. PMID: 28831016
Record last updated on November 25, 2021


Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.

About the Library

For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.

Visit our Help page for information about searching for reporting guidelines and for general information about using our website.